U.S., March 13 -- ClinicalTrials.gov registry received information related to the study (NCT07466212) titled 'QoLIDia: Quality of Life in Cancer Patients With Diabetes During Immunotherapy' on March 06.
Brief Summary: The goal of this observational study is to see how type 2 diabetes affects quality of life in cancer patients receiving immunotherapy. We want to know if patients with diabetes have a greater decline in quality of life over six months compared to those without. The main question we aim to answer is:
- How does quality of life change over six months in patients with versus without diabetes?
Participants will complete quality-of-life surveys at the start, then at 3 and 6 months. This will help us see if diabetes adds extra ch...